Work

Benralizumab for Chronic Obstructive Pulmonary Disease: Results of the Phase III GALATHEA Trial

Year: 2019

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2626

Authors: G.J. Criner, B.R. Celli, C.E. Brightling, A. Agusti, A. Papi, F.C. Sciurba, D.D. Sin, C.F. Vogelmeier, M. Kato, V.H. Shih, M. Jison, P. Newbold, M.J. Goldman, U.J. Martin, on behalf of the GALATHEA study inv

Institutions: Temple University, Brigham and Women's Hospital, Harvard University, University of Leicester, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University of Ferrara, University of Pittsburgh, St. Paul's Hospital, Centre for Heart Lung Innovation, Philipps University of Marburg, Universitätsklinikum Gießen und Marburg, German Center for Lung Research, Kishiwada City Hospital, AstraZeneca (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970507841

Cites:

Cited by:

Related to: 10